Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice

Thesis (MMed)--Stellenbosch University, 2012

Saved in:
Bibliographic Details
Main Author: Tsima, Billy Morara
Other Authors: Mash, Bob
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2017
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613799002931200
access_status_str Open Access
author Tsima, Billy Morara
author2 Mash, Bob
author_browse Mash, Bob
Tsima, Billy Morara
author_facet Mash, Bob
Tsima, Billy Morara
author_sort Tsima, Billy Morara
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MMed)--Stellenbosch University, 2012
format Thesis
id oai:scholar.sun.ac.za:10019.1/100713
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:41:52.972Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2017
publishDateRange 2017
publishDateSort 2017
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/100713 Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice Tsima, Billy Morara Mash, Bob Madzimbamuto, Farai Stellenbosch University. Faculty of Health Sciences. Department of Interdisciplinary Health Sciences. Hospitals -- Clinical practice -- Audit Cesarean section -- Botswana Pregnant women -- Botswana Oxytocin Hospitals -- Practice standards -- Botswana UCTD Thesis (MMed)--Stellenbosch University, 2012 ENGLISH ABSTRACT : Introduction Oxytocin is widely used as a uterotonic agent for preventing post partum haemorrhage. In the setting of caesarean section (CS) the dose and mode of administration of oxytocin differs according to different guidelines. This may be a source of uncertainty among the different prescribers of the drug. Most of the guidelines available, recommend a slow intravenous bolus of 5 international units (iu). Alternatively, an infusion of 20 iu over two hours is endorsed by the World Health Organisation (WHO). However, there have been many recent studies looking at the prophylactic use of oxytocin at caesarean section to prevent haemorrhage associated with the surgery. Although these studies have unequivocally shown that doses of oxytocin needed for prophylaxis against uterine atony at caesarean section are lower than those routinely used, many clinicians still use generally higher doses. Inappropriate doses of oxytocin have been indentified as contributory to some cases of maternal deaths. Aim The main aim of this study was to clinically audit the current standard of practice with regards to the use of oxytocin during caesarean section at a referral hospital in Botswana. Methods A clinical audit of pregnant women having a caesarean section (CS) and given oxytocin at the time of the operation was conducted over a three month period. Data including indications for CS; dose regimens of oxytocin; prescribing clinician designation; type of anaesthesia used for the CS; and estimated blood loss were collected. Results A total of 139 patients were included. A wide variety of dosing regimens were observed. The most common dose was 20 iu infusion (31.7%). The potentially dangerous regimen of 10 iu intravenous bolus of oxytocin was used in 12.9% of CS. Further doses were utilized in 57(41%) patients. The top three indications for CS were fetal distress 36(24.5%), dystocia 32(21.8%) and a previous CS 25(17%). Estimated blood loss (EBL) ranged from 50-2000 ml. General anaesthesia was the most popular type of anaesthesia used during the study, accounting for 64% compared to 36% where spinal anaesthesia was used. In emergency CS general anaesthesia was used in 81/115 (70.4%) of mothers as opposed to 8/24 (33.3%) of elective CS. Conclusion The use of oxytocin during CS in the local setting does not generally follow recommended practice and current literature. This has potentially harmful consequences such as increased maternal morbidity and mortality. Education and guidance by evidence based national practice guidelines and protocols could help alleviate the problem. 2017-03-20T12:06:06Z 2017-03-20T12:06:06Z 2012-03 Thesis http://hdl.handle.net/10019.1/100713 en_ZA Stellenbosch University 28 pages : illustrations (some colour) application/pdf Stellenbosch : Stellenbosch University
spellingShingle Hospitals -- Clinical practice -- Audit
Cesarean section -- Botswana
Pregnant women -- Botswana
Oxytocin
Hospitals -- Practice standards -- Botswana
UCTD
Tsima, Billy Morara
Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title_full Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title_fullStr Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title_full_unstemmed Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title_short Use of oxytocin during caesarean section at Princess Marina Hospital, Botswana: an audit of clinical practice
title_sort use of oxytocin during caesarean section at princess marina hospital botswana an audit of clinical practice
topic Hospitals -- Clinical practice -- Audit
Cesarean section -- Botswana
Pregnant women -- Botswana
Oxytocin
Hospitals -- Practice standards -- Botswana
UCTD
url http://hdl.handle.net/10019.1/100713
work_keys_str_mv AT tsimabillymorara useofoxytocinduringcaesareansectionatprincessmarinahospitalbotswanaanauditofclinicalpractice